Skip to content

Adherence to Intravitreal anti VEGF Injections in Patients with Diabetic Macular Edema

Adherence to Intravitreal anti VEGF Injections in Patients with Diabetic Macular Edema- A Cross Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/07/044292
Enrollment
380
Registered
2022-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H358- Other specified retinal disorders

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Lam Sudha Rani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic Macular Edema Patients Who Were Diagnosed Clinically and Confirmed with Spectral Domain OCT and Who are Candidates for Repeated Intravitreal anti VEGF Injections

Exclusion criteria

Exclusion criteria: Patients receiving Intravitreal anti VEGF injections for Neovascular AMD Vein Occlusions Post Operative Macular Edema Cystoid Macular Edema Uveitis

Design outcomes

Primary

MeasureTime frame
We Expect that Non Adherence to Repeated Intravitreal anti VEGF Injections in Diabetic Macular Edema Patients will be Positively Correlated to Low Socioeconomic Status Age Knowledge about the Disease Reachability of the Hospital Anxiousness Perceived Benefits Perceived Seriousness Perceived Susceptibility and Perceived BarriersTimepoint: Baseline

Secondary

MeasureTime frame
To know about the correlation between the demographic characteristics of patients and adherence to intravitreal anti VEGFs To know how much the knowledge about the disease will affect their adherence To know about the perceived seriousness perceived susceptibility perceived benefits and about the perceived barriers Timepoint: Baseline

Countries

India

Contacts

Public ContactLam Sudha Rani

Aravind Eye Hospital

manavi@aravind.org

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026